NC

nChroma Bio

8 known investors

nchromabio.com ↗

nChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications. The company works with academic founders and institutional investors focused on advancing gene therapy treatments.

Investors · 8

AT

Atlas Venture✓ verifiedCambridge · $500K – $1M

F-

F-Prime Capital✓ verified

NE

Newpath Partners✓ verifiedBoston · $50K – $10M

AR

ARCH Venture PartnersChicago · $50K – $250M

5A

5AM VenturesreportedBoston · $100K – $4M

DC

DCVC (Data Collective)reportedPalo Alto · $5M – $25M

DC

DCVC BioreportedPalo Alto

OM

Omega FundsreportedBoston